Katherine Hrynewycz, MD
Dermatology · Carmel, INNPI 1407267115
Payments from drug & device makers
Across 69 payments — averaging $72.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$3K
- Regeneron Healthcare Solutions, Inc.$344
- Solta Medical, A Division Of Bausch Health US, LLC$265
- AbbVie$231
- Lilly USA, LLC$167
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$150
- plus $753 from 13 others
What the payments were for
- Food & beverage$2,22445%
- Other$2,75555%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 15 | $3,069 |
| Regeneron Healthcare Solutions, Inc. | 8 | $344 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $265 |
| AbbVie | 3 | $231 |
| Lilly USA, LLC | 8 | $167 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $150 |
| Incyte Corporation | 6 | $142 |
| Johnson & Johnson | 5 | $123 |
| Merz North America, Inc. | 1 | $105 |
| Amgen | 6 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $88 |
| UCB, Inc. | 2 | $39 |
| Mayne Pharma Commercial LLC | 5 | $30 |
| Almirall LLC | 1 | $30 |
| Boehringer Ingelheim | 1 | $21 |
| Sandoz | 1 | $20 |
| Botanix SB Inc | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL$2,064
- INTEGRA$939
- INTEGRA DERMAL REGENERATION TEMPLATE$313
- PRIMATRIX$313
- AMNIOEXCEL PLUS$261
- MICROMATRIX$175
- CYTAL$144
- LIBTAYO$129
- SILIQ$125
- DUPIXENT$106
How this compares
$4,979 in reported general payments places this provider in the 50th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 93 | $354 |
| Mupirocin | 47 | $328 |
| Doxycycline Hyclate | 38 | $211 |
| Azithromycin | 16 | $73 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $36 |
| Amoxicillin | 25 | $31 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Carmel
- John StephensCarmel$17K
- Andrew BridgeCarmel$15K
- Robert DazeCarmel$10K
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.